[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.83.210. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
December 16, 2009

Data Error in Text in: Laser Photocoagulation and Intravitreal Injection of Triamcinolone for Retinal Vein Occlusions

JAMA. 2009;302(23):2554. doi:10.1001/jama.2009.1835

Data Error in Text: In the From the Archives Journals commentary entitled “Laser Photocoagulation and Intravitreal Injection of Triamcinolone for Retinal Vein Occlusions” published in the October 21, 2009, issue of JAMA (2009;302[15]:1693-1695), data were incorrectly presented on the second page. In the fifth paragraph (beginning “The data from the SCORE CRVO trial”), the second sentence should read: “Approximately 27% of the participants in the 1 mg of triamcinolone group, 26% of the 4 mg of triamcinolone group, and 7% of the observation group gained 3 lines or more vision at 1 year.”

×